Zeitschriftenaufsatz
|
2021
Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis.
Autor:in
Redl, Elisa; Sheibani-Tezerji, Raheleh; Cardona, Crhistian de Jesus; Hamminger, Patricia; Timelthaler, Gerald; Hassler, Melanie Rosalia; Zrimšek, Maša; Lagger, Sabine; Dillinger, Thomas; Hofbauer, Lorena; Draganić, Kristina; Tiefenbacher, Andreas; Kothmayer, Michael; Dietz, Charles H; Ramsahoye, Bernard H; Kenner, Lukas; Bock, Christoph; Seiser, Christian; Ellmeier, Wilfried; Schweikert, Gabriele; Egger, Gerda
Publikationen als Autor:in / Herausgeber:in der Vetmeduni
Journal
Schlagwörter
Animals; Biomarkers, Tumor; Cell Transformation, Neoplasticgeneticsmetabolism; Computational Biologymethods; DNA (Cytosine-5-)-Methyltransferase 1geneticsmetabolism; DNA Methylation; Disease Models, Animal; Disease Susceptibility; Epigenesis, Genetic; Epigenomics; Gene Deletion; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Immunohistochemistry; Immunophenotyping; Lymphomadrug therapyetiologymetabolismpathology; Mice; Mice, Knockout; Mice, Transgenic; Protein-Tyrosine Kinasesgeneticsmetabolism; STAT3 Transcription Factormetabolism; Signal Transduction; Xenograft Model Antitumor Assays
Dokumententyp
Originalarbeit
CC Lizenz
CCBY
Open Access Type
Hybrid
ISSN/eISSN
2575-1077 - 2575-1077
10.26508/lsa.202000794
WoS ID
PubMed ID